Cargando…

Immune status for monitoring and treatment of bladder cancer

The high recurrence rate of non-muscle invasive bladder cancer (BC) and poor prognosis of advanced BC are therapeutic challenges that need to be solved. Bacillus Calmette-Guerin (BCG) perfusion was the pioneer immunotherapy for early BC, and the discovery of immune checkpoint inhibitors has created...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Shen, Li, Shijie, Zhan, Yunhong, Chen, Xiaonan, Sun, Ming, Liu, Xuefeng, Wu, Bin, Li, Zhenhua, Liu, Bitian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492838/ https://www.ncbi.nlm.nih.gov/pubmed/36159866 http://dx.doi.org/10.3389/fimmu.2022.963877

Ejemplares similares

Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors
por: Pan, Shen, et al.
Publicado: (2019)

Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices
por: Pan, Shen, et al.
Publicado: (2019)

Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer
por: Li, Shijie, et al.
Publicado: (2023)

Identification of a Gene Signature for Renal Cell Carcinoma–Associated Fibroblasts Mediating Cancer Progression and Affecting Prognosis
por: Liu, Bitian, et al.
Publicado: (2021)

Laparoscopic ultrasonography: The wave of the future in renal cell carcinoma?
por: Liu, Bitian, et al.
Publicado: (2018)

Phosphorylated MAPK14 Promotes the Proliferation and Migration of Bladder Cancer Cells by Maintaining RUNX2 Protein Abundance
por: Liu, Junlong, et al.
Publicado: (2020)

Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study
por: Li, Shijie, et al.
Publicado: (2021)

Downregulation of miR‐133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder
por: Chen, Xiaonan, et al.
Publicado: (2016)

IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer
por: Yi, Xianyanling, et al.
Publicado: (2022)

Association Between the Pretreatment Albumin-to-Alkaline Phosphatase Ratio and Clinical Outcomes in Patients With Bladder Cancer Treated With Radical Cystectomy: A Retrospective Cohort Study
por: Li, Shijie, et al.
Publicado: (2021)

Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer
por: Li, Tianhang, et al.
Publicado: (2022)

Transcriptome analysis reveals immune and metabolic regulation effects of Poria cocos polysaccharides on Bombyx mori larvae
por: Liu, Jiajie, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte Ratio: A Biomarker to Monitor the Immune Status of Astronauts
por: Paul, Amber M., et al.
Publicado: (2020)

Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine
por: Sun, Zhuolun, et al.
Publicado: (2023)

Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy
por: Zhang, Yao-Yu, et al.
Publicado: (2022)

The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer
por: Li, Jinze, et al.
Publicado: (2022)

Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bladder urothelial cancer
por: Xu, Chao, et al.
Publicado: (2023)

The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy
por: Lu, Chenglin, et al.
Publicado: (2023)

Common molecular mechanism and immune infiltration patterns of thoracic and abdominal aortic aneurysms
por: He, Bin, et al.
Publicado: (2022)

Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression
por: Yao, Ren-Qi, et al.
Publicado: (2022)

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
por: Wu, Xiangkun, et al.
Publicado: (2020)

Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
por: Qi, Yangzhi, et al.
Publicado: (2020)

The immune responses to different Uropathogens call individual interventions for bladder infection
por: Li, Linlong, et al.
Publicado: (2022)

Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy
por: Xiao, Ying, et al.
Publicado: (2022)

Pan-cancer Landscape of the RUNX Protein Family Reveals their Potential as Carcinogenic Biomarkers and the Mechanisms Underlying their Action
por: Pan, Shen, et al.
Publicado: (2022)

Prognostic Effect of Subclassification on Oncological Outcomes in Patients with Surgically Treated Localized Papillary Renal Cell Carcinoma: A Retrospective Propensity Score-matched Cohort Study
por: Li, Shijie, et al.
Publicado: (2022)

A novel cuproptosis pattern and tumor immune microenvironment characterization in urothelial carcinoma of the bladder
por: Feng, Huan, et al.
Publicado: (2023)

A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma
por: Du, Kunpeng, et al.
Publicado: (2022)

TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer
por: Cui, Jin-Huan, et al.
Publicado: (2018)

Standardization of neutrophil CD64 and monocyte HLA-DR measurement and its application in immune monitoring in kidney transplantation
por: Peng, Bo, et al.
Publicado: (2022)

The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer
por: Zhao, Zihan, et al.
Publicado: (2023)

Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
por: Chang, Zhenglin, et al.
Publicado: (2022)

The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition
por: van Dorp, Jeroen, et al.
Publicado: (2023)

The Combined Model of CX3CR1-Related Immune Infiltration Genes to Evaluate the Prognosis of Idiopathic Pulmonary Fibrosis
por: Cai, Haozheng, et al.
Publicado: (2022)

A versatile toolkit for overcoming AAV immunity
por: Li, Xuefeng, et al.
Publicado: (2022)

Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer
por: Xu, Ting, et al.
Publicado: (2022)

Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients
por: Li, Shun, et al.
Publicado: (2021)

ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer
por: Shen, Xiaonan, et al.
Publicado: (2022)

Machine learning-based prognostic modeling of lysosome-related genes for predicting prognosis and immune status of patients with hepatocellular carcinoma
por: Li, Wenhua, et al.
Publicado: (2023)

RUNX2 interacts with SCD1 and activates Wnt/β‐catenin signaling pathway to promote the progression of clear cell renal cell carcinoma
por: Song, Xiandong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_97vep8jv3vr2i486dpp069fr19